Associate Members
iBET’s Associate Members benefit from first-in-line access to iBET’s scientific expertise in both Biopharma and Sustainability for Food & Health.

iBET Associate Members
iBET’s Associate Members consist of 60% private and 40% public organizations. These include leading companies from the national Pharmaceutical and Agro-industry sectors, as well as academic and other public institutions.
Our associates enjoy privileged access to iBET’s multidisciplinary scientific expertise across all areas of competence. This status provides the opportunity to develop R&D projects, access existing services, and propose new areas of development, services, and competences.
Pharma and Healthcare



Agro-Industry

Academia

Foundations and Institutes


Benefits for Associates
Associate Members benefit from:
- Privileged access across all areas of scientific expertise for the development of R&D projects (with a discount on related R&D services);
- Support to Innovation and assessment of new business opportunities;
- Use of the “Access Fee” model to streamline and broaden overall collaboration between the Associate and iBET;
- Advanced Training;
- Preparation of Technical Reports;
- Technical and Scientific Consultancy;
- Manufacturing and Quality Assurance Audits;
Download Benefits for Associates [PT]
Tax Benefits
Donations granted to iBET are considered as expenses under the scientific patronage, as foreseen in the Tax Benefits Statute (Art. 62º A do Estatuto dos Benefícios Fiscais) as a result from its status of private non-profit research organization in the scientific area. (Despacho nº 3951/2024, Diário da República, 2ª série).
SIFIDE II is a system of tax incentives for entrepreneurial R&D, approved by the Decree-Law nº 162/2014, and in force until 2025 (Law nº 2/2020). According to that system all the costs related to R&D activities supplied by R&D institutions are eligible expenses for the purpose of that incentive. iBET, as part of “Sistema Cientifico e Tecnológico Nacional”, fully qualifies as a R&D institution for the purpose of this incentive scheme.
Intellectual Property Policy
In research work carried out with companies, the ownership is often attributed to companies, with iBET and the inventors collecting royalties. For patents filed directly by iBET, we try to market them as soon as they are filed with relevant companies as these can better use them in their business activities.